204 related articles for article (PubMed ID: 21129837)
21. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
[TBL] [Abstract][Full Text] [Related]
22. Eczema-like plaques to enoxaparin.
Valdés F; Vidal C; Fernández-Redondo V; Peteiro C; Toribio J
Allergy; 1998 Jun; 53(6):625-6. PubMed ID: 9689351
[No Abstract] [Full Text] [Related]
23. Delayed-type hypersensitivity to subcutaneous enoxaparin.
Méndez J; Sanchís ME; de la Fuente R; Stolle R; Vega JM; Martínez C; Armentia A; Sánchez P; Fernández A
Allergy; 1998 Oct; 53(10):999-1003. PubMed ID: 9821483
[TBL] [Abstract][Full Text] [Related]
24. Regarding "Anticoagulation with enoxaparin versus intravenous unfractionated heparin in postoperative vascular surgery patients".
Paramo JC; Sendzischew H; Sivina M
J Vasc Surg; 2003 Mar; 37(3):700-1; author reply 701. PubMed ID: 12618719
[No Abstract] [Full Text] [Related]
25. Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection.
Trunfio M; Salvador E; Cabodi D; Marinaro L; Alcantarini C; Gaviraghi A; Trentalange A; Lipani F; Sciascia S; Roccatello D; Bonora S; Di Perri G; Calcagno A;
Thromb Res; 2020 Dec; 196():432-434. PubMed ID: 33049598
[No Abstract] [Full Text] [Related]
26. Delayed hypersensitivity at the injection sites of a low-molecular-weight heparin.
Moreau A; Dompmartin A; Esnault P; Michel M; Leroy D
Contact Dermatitis; 1996 Jan; 34(1):31-4. PubMed ID: 8789222
[TBL] [Abstract][Full Text] [Related]
27. Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: tolerance of a new recombinant hirudin.
Koch P; Münssinger T; Rupp-John C; Uhl K
J Am Acad Dermatol; 2000 Apr; 42(4):612-9. PubMed ID: 10727306
[TBL] [Abstract][Full Text] [Related]
28. New oral anticoagulants in venous thromboembolism prophylaxis in orthopaedic patients: are they really better?
Huo MH
Thromb Haemost; 2011 Jul; 106(1):45-57. PubMed ID: 21544312
[TBL] [Abstract][Full Text] [Related]
29. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
[TBL] [Abstract][Full Text] [Related]
30. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
Omran H; Hammerstingl C; Paar WD;
Med Klin (Munich); 2007 Oct; 102(10):809-15. PubMed ID: 17928964
[TBL] [Abstract][Full Text] [Related]
31. [Delayed-type allergy for heparin and fractions of low-molecular-weight heparin].
de Kort WJ; van der Meer YG; de Groot AC
Ned Tijdschr Geneeskd; 1992 Nov; 136(48):2379-80. PubMed ID: 1334235
[TBL] [Abstract][Full Text] [Related]
32. Immediate type hypersensitivity to low molecular weight heparins and tolerance of unfractioned heparin and fondaparinux.
Harr T; Scherer K; Tsakiris DA; Bircher AJ
Allergy; 2006 Jun; 61(6):787-8. PubMed ID: 16677252
[No Abstract] [Full Text] [Related]
33. [General perioperative prevention of thromboembolism in gynecology with low-molecular weight heparin: clinical experiences with enoxaparin over 7 years].
Slunsky R
Zentralbl Gynakol; 1995; 117(11):598-601. PubMed ID: 8533494
[TBL] [Abstract][Full Text] [Related]
34. Delayed allergic skin reactions to subcutaneous heparins. Tolerance of 2 recombinant hirudins.
Koch P; Reinhold S; Busch C
Contact Dermatitis; 2000 May; 42(5):278-9. PubMed ID: 10789845
[No Abstract] [Full Text] [Related]
35. [Enoxaparin-induced cutaneous necrosis localized on insulin lipodystrophies].
Lefebvre I; Delaporte E; Dejobert Y; Catteau B; Piette F; Bergoend H
Ann Dermatol Venereol; 1997; 124(5):397-400. PubMed ID: 9739898
[TBL] [Abstract][Full Text] [Related]
36. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight. Commentary.
Gómez-Outes A; Gómez de la Bárcena C; Martínez-González J
Br J Dermatol; 2008 Apr; 158(4):869-70. PubMed ID: 18284394
[No Abstract] [Full Text] [Related]
37. [Daily thrombocyte count in low molecular weight heparin treatment].
Spannagl M
Chirurg; 2008 Mar; Suppl():85. PubMed ID: 18711818
[No Abstract] [Full Text] [Related]
38. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
39. [Can thrombosis be prevented through immediate postoperative low-molecular-weight-heparin prophylaxis?].
Bank I; Büller HR
Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2031. PubMed ID: 11072524
[No Abstract] [Full Text] [Related]
40. Prevention of thrombosis during pregnancy.
Vilela VS; de Jesús NR; Levy RA
Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
